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Objectives: To identify predictors of: uptake of the childhood influenza vaccine in the 2015–2016 influ-
enza season, parental perceptions of side-effects from the influenza vaccine and intention to vaccinate
one’s child for influenza in the 2016–2017 influenza season.
Design: Cross-sectional online survey.
Setting: Data were collected in England shortly after the end of the 2015–2016 immunization campaign.
Participants: 1001 parents or guardians of children aged between two and seven.
Main outcome measures: Self-reported uptake of the childhood influenza vaccine in the 2015–2016 influ-
enza season, perception of side-effects from the influenza vaccine and intention to vaccinate one’s child
in the 2016–2017 influenza season.
Results: Self-reported uptake of the childhood influenza vaccine was 52.8%. Factors strongly positively
associated with uptake included the child having previously been vaccinated against influenza, perceiv-
ing the vaccine to be effective and perceiving the child to be susceptible to flu. Factors strongly negatively
associated with uptake included perceiving the vaccine to be unsafe, to cause short-term side-effects or
long-term health problems and believing that yearly vaccination may overload the immune system.
Predictors of intended vaccine uptake in 2016–2017 were similar. Participants who perceived side-
effects after the 2015–2016 vaccination reported being less likely to vaccinate their child next year.
Side-effects were more likely to be reported in first-born children, by participants who knew another
child who had side-effects, those who thought that the vaccine would interact with medication that
the child was currently taking, and those who believed the vaccine causes short-term side-effects.
Conclusions: Perceptions about the childhood influenza vaccine show strong associations with uptake,
intended uptake and perception of side-effects. Attempts to improve uptake rates from their current
low levels must address these perceptions.
 2017 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
In 2012, the British Joint Committee on Vaccination and Immu-
nisation (JCVI) recommended that the influenza vaccination pro-
gramme be extended to include children aged two to sixteen, in
an attempt to limit the number of children who suffer from com-
plications of influenza and to reduce morbidity and mortality
among adults who may contract influenza from children. In the
first two influenza seasons that the vaccine was offered to children,
uptake in those aged two to four was around 30–40% [1,2]. In the
2015–2016 flu season, the influenza vaccine was offered to all
two to four year olds via their GP and five to seven year olds in
school (school years one and two). Children were offered the nasal
flu spray (live attenuated influenza vaccine, Fluenz Tetra); if con-
traindicated, children were offered an inactivated vaccine (injec-
tion) [3]. Initial yearly figures for the 2015–2016 influenza
season indicate that uptake was 30.0–37.7% in children aged two
to four, 54.4% in children in school year one, and 52.9% in children
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in school year two [4], falling short of the Public Health England
target of 40–60% uptake in two to four year olds [3].
Factors associated with parental rejection of other vaccinations
for their children include poorer parental socio-economic and
employment status [5]; believing that the vaccine is unsafe [6] or
ineffective [7], and that children are given too many vaccines [8].
Concerns that the vaccine causes side-effects are also commonly
cited as reasons for not wanting to vaccinate one’s child [7,9–11].
Although acute symptoms are common following many vacci-
nations, their causes are not always straightforward. While some
may be directly attributable to vaccination, others may reflect
pre-existing or coincidental symptoms that are misattributed to
the vaccine, while still others may occur due to a ‘nocebo’ effect
triggered by a self-fulfilling expectation of symptoms [12–14].
Expectations may be caused by seeing someone else experience
symptoms after vaccination [15] or through exposure to informa-
tion suggesting that side-effects are common.
We used a cross-sectional survey of parents whose child was
eligible to receive the influenza vaccine in England during the
2015–2016 influenza season to test whether self-reported uptake
of the vaccine and parental perception of side-effects were associ-
ated with attitudes towards influenza and the vaccine. We also
tested whether these factors, together with parental perception
of side-effects, were associated with intention to have their child
vaccinated in the 2016–2017 season. Items assessing parental
understanding of current messages about these issues were also
included, in order to test the clarity of current communication
about the risk of side-effects and the efficacy of the vaccine.
2. Method
2.1. The survey
We commissioned the market research company Ipsos MORI to
conduct an online survey of parents or guardians of children aged
between two and seven years on 31st August 2015 living in Eng-
land. Data collection took place between 16th and 30th March 2016.
Ipsos MORI recruited participants from an existing panel of peo-
ple willing to take part in internet surveys (n = 160,000 in Eng-
land). Quotas based on parent age and gender (combined),
location, working status, gender of child and age of child were
set to reflect the known demographic profile of parents of children
in England [16]. We intended to recruit 1000 participants to pro-
vide us with a sample error of about plus or minus 3%. Panel par-
ticipants typically receive points for every survey they complete:
for our survey, participants received points worth 75p. The study
was approved by the King’s College London Psychiatry, Nursing
and Midwifery Research Ethics subcommittee (reference number
HR-15/16-2132).
2.1.1. Selection of index child
Where participants had two or more eligible children, the sur-
vey software chose one child for them to think about when
answering questions, based on the need to fill quotas for child
age. If parents had two children of the same age, they were asked
to choose one to think about for the duration of the survey.
2.1.2. Vaccine uptake, perception of side-effects and intended vaccine
uptake
Participants were asked whether their child had received the
influenza vaccination ‘‘this winter (2015/16)” and to state their
main reasons for vaccinating or not vaccinating their child. Partic-
ipants whose child had been vaccinated were asked whether the
child had experienced any out of a list of 23 symptoms ‘‘because
of the child flu vaccine.” We included symptoms listed as vaccine
side-effects by the manufacturer, common symptoms taken from
the Patient Health Questionnaire (PHQ-15 [17]) and other symp-
toms suggested by the literature [18] or by parents during our
piloting. Participants who reported symptoms were asked how
severe, overall, the symptoms had been and how worried they
had been about them. Two items, based on those used by Paya-
prom et al. [19], asked participants to rate on a five point scale
whether they wanted or intended the child to be vaccinated for
influenza next year.
2.1.3. Personal characteristics and perceptions and attitudes about
influenza and the vaccination
We asked participants to report personal characteristics (see
Table 1). Participants also rated 19 statements relating to the par-
ticipant’s perceptions of influenza and vaccination (see Table 2),
adapted from previous work [20] on a 5-point Likert scale from
‘‘strongly agree,” to ‘‘strongly disagree.”
2.1.4. Terminology used in vaccine communications
Understanding of current communications regarding the effec-
tiveness of the vaccine was assessed by one item asking partici-
pants to imagine that the childhood influenza vaccine was ‘‘50%
effective.” Participants endorsed one of five options for what this
means, including the correct answer ‘‘if a child had a 50% chance
of catching flu before being vaccinated, they now have half that
chance (i.e. 25%).”
We included four items to assess understanding of terms used
to communicate the incidence of acute side-effects. The four items
described side-effects that were ‘‘very common” (runny or stuffy
nose), ‘‘common” (fever), ‘‘uncommon” (rash) and ‘‘very rare” (sev-
ere allergic reaction) as indicated by the patient information leaflet
[21]. These terms are recommended for use in patient information
leaflets by European Commission guidelines and are intended to
reflect side-effects that affect more than one in ten patients (very
common), up to one in ten (common), up to one in 100 (uncom-
mon) and up to one in 10,000 (very rare) [22]. Items stated, for
example, that ‘‘the patient information leaflet mentions that fever
is a common side-effect” and asked participants to estimate how
many out of 10,000 vaccinated children would develop the speci-
fied symptom. The patient information leaflet does not describe
any ‘‘rare” side-effects, so participants’ understanding of this term
was not assessed.
2.2. Analysis
Where relevant, we excluded data from participants who did
not know or could not remember if their child had been vaccinated
or had experienced side-effects. Scores for the two items assessing
intention to vaccinate in 2016–2017 were combined to produce an
intention score from 2 to 10 [19], with a higher score indicating a
stronger intention. If participants had answered ‘‘don’t know” to
one or both intention questions they were excluded from the
intention analysis. We defined a score of six or lower as indicating
a low intention to vaccinate again in the next year, and a score of
seven or more as high intention.
We recoded perceptions and attitudes about influenza and the
vaccine as ‘‘agree” or ‘‘disagree”. Responses of ‘‘don’t know” and
‘‘neither agree nor disagree” were treated as missing data. Binary
logistic regressions were used to calculate univariate associations
between perceptions, personal characteristics and outcomes.
Multivariate logistic regressions were used to calculate the same
associations adjusting for personal characteristics. Associations
between personal characteristics, perceptions and side-effect
reporting, side-effect severity and side-effect worry with the
outcome ‘intended vaccination’ were calculated using linear
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regressions, with a second set of linear regressions adjusting for
personal characteristics. Only results of multivariate analyses are
reported narratively; results of univariate analyses are shown in
the tables.
Because rates of reported vaccine uptake, perceived side-effects,
and intention to vaccinate the child did not change by more than
1% when using data weighted by age, gender, region and working
status, we used unweighted data for our analyses.
Table 1
Participants’ personal characteristics and associations with influenza vaccine uptake and intention to vaccinate.
Participant characteristics Level Influenza vaccine uptake Intention to vaccinate child next flu
season
Vaccinated
n = 529
Not
vaccinated
n = 438
Odds ratio
(95% CI)
Adjusted odds
ratio (95% CI)b
Mean
(SD)
B (95% CI) Adjusted B
(95% CI)b
Parent gender Male 212 (52.6) 191 (47.4) Reference Reference 7.59
(2.35)
Reference Reference
Female 317 (55.9) 247 (44.1) 1.16 (0.89–
1.50)
1.13 (0.79–1.64) 7.66
(2.59)
0.06 (0.26
to 0.38)
0.06
(0.39 to
0.27)
Parent age 18–34 238 (60.7) 154 (39.3) Reference Reference 7.84
(2.45)
Reference Reference
35–44 238 (53.0) 211 (47.0) 0.73 (0.56–
0.96)
0.88 (0.60–1.28) 7.58
(2.48)
0.26 (0.60
to 0.08)
0.05
(0.38 to
0.29)
45+ 53 (42.1) 73 (57.9) 0.47 (0.31–
0.71)
0.84 (0.47–1.50) 7.10
(2.59)
0.74 (1.25
to 0.23)
0.35
(0.88 to
0.17)
Parent employment Not working 126 (53.8) 108 (46.2) Reference Reference 7.66
(2.78)
Reference Reference
Working 403 (55.0) 330 (45.0) 1.05 (0.78–
1.41)
0.98 (0.63–1.52) 7.62
(2.40)
0.04 (0.41
to 0.34)
0.15
(0.55 to
0.25)
Total household income before
tax and other deductions
Under <£30,000 191 (56.7) 146 (43.3) Reference Reference 7.74
(2.60)
Reference Reference
£30,000 311 (54.3) 262 (46.7) 0.91 (0.69–
1.19)
0.88 (0.60–1.29) 7.63
(2.39)
0.10 (0.44
to 0.23)
0.07
(0.41 to
0.28)
Parent highest educational or
professional qualification
GCSE/vocational/A-level/
No formal qualifications
230 (54.1) 195 (45.9) Reference Reference 7.62
(2.63)
Reference Reference
Degree or higher
(Bachelors, Masters, PhD)
289 (55.5) 232 (44.5) 1.06 (0.82–
1.37)
1.18 (0.82–1.71) 7.66
(2.35)
0.03 (0.29
to 0.35)
0.02 (0.31
to 0.35
Ethnicity White 456 (56.0) 358 (44.0) Reference Reference 7.68
(2.48)
Reference Reference
Black and Minority 66 (48.9) 69 (51.1) 0.75 (0.52–
1.08)
0.69 (0.42–1.12) 7.49
(2.50)
0.20 (0.65
to 0.26)
0.16
(0.61 to
0.28)
Parent chronic illness None 343 (52.4) 312 (47.6) Reference Reference 7.52
(2.56)
Reference Reference
Present 183 (59.6) 124 (40.4) 1.34 (1.02–
1.77)
1.06 (0.71–1.57) 7.84
(2.34)
0.32 (0.19
to 0.66)
0.12 (0.23
to 0.47)
Child gender Male 259 (54.4) 217 (45.6) Reference Reference 7.62
(2.46)
Reference Reference
Female 270 (55.0) 221 (45.0) 1.02 (0.80–
1.32)
1.23 (0.87–1.73) 7.63
(2.53)
0.01 (0.31
to 0.33)
0.15 (0.16
to 0.46)
First-born child No 210 (47.1) 236 (53.9) Reference Reference 7.45
(2.64)
Reference Reference
Yes 319 (61.2) 202 (38.8) 1.78 (1.37–
2.29)
1.35 (0.95–1.93) 7.78
(2.35)
0.34 (0.02–
0.66)
0.05
(0.37 to
0.27)
Child agea 4.52 (1.68) 0.92 (0.85–
0.99)
0.96 (0.87–1.06) 7.63
(2.49)
0.09 (0.18
to 0.01)
0.04
(0.13 to
0.05)
Child chronic illness None 421 (52.4) 383 (47.6) Reference Reference 7.54
(2.55)
Reference Reference
Present 103 (66.9) 51 (33.1) 1.84 (1.28–
2.64)
1.36 (0.82–2.26) 8.04
(2.15)
0.51 (0.08–
0.93)
0.02 (0.42
to 0.46)
Child previous flu vaccine No 79 (19.9) 318 (80.1) Reference Reference 6.24
(2.78)
Reference Reference
Yes 434 (81.0) 102 (19.0) 17.13
(12.35–
23.76)
15.54 (11.00–
21.96)
8.61
(1.72)
2.37 (2.08–
2.67)
2.25 (1.94–
2.57)
Results highlighted in bold are significant.
a Continuous variable. Presented as mean (sd).
b Adjusting for all other personal characteristics (both parent and child).
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Table 2
Associations between attitudes and perceptions vaccine uptake and intention to vaccinate.
Perception statement Level Influenza vaccine uptake Intention to vaccinate child next flu
season
Vaccinated
n = 529
Not
vaccinated
n = 438
Odds ratio
(95% CI)
Adjusted odds
ratio (95% CI)a
Mean
(SD)
B (95% CI) Adjusted B
(95% CI)a
The child flu vaccine has not been tested enough
for me to feel it is safe
Disagree 315 (77.8) 90 (22.2) Reference Reference 8.82
(1.64)
Reference Reference
Agree 89 (34.9) 166 (65.1) 0.15
(0.11–
0.22)
0.16 (0.10–0.26) 6.48
(2.80)
2.34 (2.68
to 2.00)
1.78 (2.12
to 1.44)
The child flu vaccine can cause unpleasant short-
term side-effects
Disagree 151 (79.5) 39 (20.5) Reference Reference 8.89
(1.55)
Reference Reference
Agree 206 (47.5) 228 (52.5) 0.23
(0.16–
0.35)
0.26 (0.16–0.43) 7.13
(2.73)
1.76 (2.18
to 1.35)
1.37 (1.77
to 0.96)
The child flu vaccine can cause long-term health
problems
Disagree 293 (72.9) 109 (27.1) Reference Reference 8.69
(1.72)
Reference Reference
Agree 86 (45.5) 103 (54.5) 0.31
(0.22–
0.45)
0.26 (0.15–0.42) 6.64
(2.92)
2.05 (2.43
to 1.67)
1.83 (2.22
to 1.45)
The flu vaccine would interact with other
medications that [child] is currently taking
Disagree 370 (55.1) 302 (44.9) Reference Reference 7.66
(2.59)
Reference Reference
Agree 71 (64.5) 39 (35.5) 1.49
(0.98–
2.26)
0.74 (0.41–1.32) 8.21
(1.96)
0.55 (0.04–
1.06)
0.05 (0.46
to 0.55)
Vaccinating [child] against flu each year will
overload his/her immune system
Disagree 316 (68.7) 144 (31.3) Reference Reference 8.54
(2.03)
Reference Reference
Agree 90 (45.0) 110 (55.0) 0.37
(0.27–
0.52)
0.27 (0.16–0.44) 6.92
(2.67)
1.62 (2.00
to 1.25)
1.43 (1.80
to 1.05)
Another child I know had side-effects from the
vaccine
Disagree 312 (56.5) 240 (43.5) Reference Reference 7.96
(2.41)
Reference Reference
Agree 113 (58.9) 79 (41.1) 1.10
(0.79–
1.54)
0.647 (0.41–
1.02)
7.49
(2.58)
0.48 (0.88
to 0.73)
0.83 (1.21
to 0.44)
A health professional has recommended that
[child] should be vaccinated
Disagree 112 (33.6) 211 (66.4) Reference Reference 6.66
(2.75)
Reference Reference
Agree 284 (76.3) 88 (23.7) 6.08
(4.37–
8.47)
3.61 (2.36–5.50) 8.61
(1.98)
1.95 (1.59–
2.30)
1.11 (0.72–
1.49)
A health professional has recommended that
[child] shouldn’t be vaccinated
Disagree 381 (57.6) 280 (42.4) Reference Reference 7.79
(2.50)
Reference Reference
Agree 84 (62.7) 50 (37.3) 1.24
(0.84–
1.81)
0.853 (0.51–
1.44)
7.95
(2.28)
0.16 (0.30
to 0.63)
0.13 (0.58–
0.32)
A friend/relative has recommended that [child]
shouldn’t be vaccinated
Disagree 363 (56.8) 276 (43.2) Reference Reference 7.84
(2.51)
Reference Reference
Agree 90 (60.0) 60 (40.0) 1.14
(0.79–
1.64)
0.73 (0.45–1.18) 7.77
(2.33)
0.07 (0.51
to 0.38)
0.41 (0.85
to 0.02)
If I don’t vaccinate [child], then [child] will get flu Disagree 66 (25.2) 196 (74.8) Reference Reference 5.43
(2.67)
Reference Reference
Agree 225 (74.8) 76 (25.2) 8.79
(6.00–
12.87)
4.46 (2.66–7.48) 8.85
(1.62)
3.42 (3.06–
3.78)
2.90 (2.48–
3.31)
Flu would be a serious illness for [child] Disagree 69 (38.8) 109 (61.2) Reference Reference 6.25
(3.04)
Reference Reference
Agree 370 (62.2) 225 (37.8) 2.60
(1.84–
3.67)
1.66 (1.03–2.66) 8.26
(2.09)
2.01 (1.61–
2.41)
1.40 (0.99–
1.81)
Flu would be a serious illness for me Disagree 113 (43.3) 148 (56.7) Reference Reference 6.65
(2.93)
Reference Reference
Agree 287 (62.0) 176 (38.0) 2.14
(1.57–
2.91)
1.40 (0.92–2.13) 8.26
(2.07)
1.61 (1.24–
1.98)
0.97 (0.60–
1.35)
Flu would be a serious illness for someone living
in [child]’s household
Disagree 98 (45.2) 119 (54.8) Reference Reference 6.47
(2.96)
Reference Reference
Agree 301 (61.6) 188 (38.4) 1.94
(1.41–
2.69)
1.36 (0.87–2.12) 8.24
(2.19)
1.78 (1.38–
2.17)
1.27 (0.88–
1.66)
(continued on next page)
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3. Results
3.1. Participants
Of 11,563 people emailed the link to the survey, 1310 began it.
After removing those who did not complete the survey (n = 268),
who completed suspiciously quickly or who provided identical
answers to multiple consecutive questions (‘‘speeding” or
‘‘straightlining;” n = 34), or who experienced a technical malfunc-
tion during the survey (n = 7), 1001 parents or guardians com-
pleted the study (response rate = 8.7%).
Personal characteristics of participants and their children are
shown in Table 1.
3.2. Vaccine uptake
529 participants (52.8%) reported that their child had been vac-
cinated for influenza in the 2015–2016 season, 441 (44.1%)
reported that their child had not been vaccinated and 34 (3.4%)
did not know. Participants’ reasons for vaccinating or not vaccinat-
ing their child are reported in the supplementary materials. The
most common reason for vaccinating was to protect the child from
Table 2 (continued)
Perception statement Level Influenza vaccine uptake Intention to vaccinate child next flu
season
Vaccinated
n = 529
Not
vaccinated
n = 438
Odds ratio
(95% CI)
Adjusted odds
ratio (95% CI)a
Mean
(SD)
B (95% CI) Adjusted B
(95% CI)a
Having the child flu vaccine is an effective way of
preventing [child] from catching flu
Disagree 29 (23.4) 95 (76.6) Reference Reference 4.62
(2.77)
Reference Reference
Agree 427 (71.6) 169 (28.4) 8.28
(5.27–
13.01)
4.56 (2.58–8.08) 8.75
(1.63)
4.14 (3.77–
4.51)
3.43 (3.03–
3.82)
I don’t like [child] having vaccinations in general Disagree 308 (63.0) 181 (37.0) Reference Reference 8.26
(2.23)
Reference Reference
Agree 103 (47.2) 115 (52.8) 0.53
(0.38–
0.73)
0.53 (0.34–0.82) 6.71
(2.95)
1.55 (1.96
to 1.15)
1.34 (1.73
to 0.95)
I don’t know enough about the child flu vaccine Disagree 242 (77.3) 71 (22.7) Reference Reference 8.49
(2.23)
Reference Reference
Agree 124 (32.8) 254 (67.2) 0.14
(0.10–
0.20)
0.16 (0.10–0.25) 6.80
(2.61)
1.69 (2.06
to 1.32)
1.08 (1.45
to 0.70)
Vaccinating [child] against flu each year is too
much of an ongoing time commitment
Disagree 381 (60.3) 251 (39.7) Reference Reference 7.96
(2.47)
Reference Reference
Agree 82 (60.3) 54 (39.7) 1.00
(0.68–
1.46)
0.59 (0.35–1.00) 7.74
(2.26)
0.22 (0.67
to 0.23)
0.48 (0.94
to 0.03)
The child flu vaccine does not suit my religious or
cultural beliefs/values
Disagree 385 (57.0) 291 (43.0) Reference Reference 7.90
(2.38)
Reference Reference
Agree 74 (62.2) 45 (37.8) 1.24
(0.83–
1.86)
0.93 (0.54–1.61) 7.57
(2.60)
0.33 (0.81
to 0.14)
0.55 (1.02
to 0.09)
The vaccination campaign is just about making
money for the manufacturers
Disagree 314 (70.4) 132 (29.4) Reference Reference 8.59
(1.86)
Reference Reference
Agree 77 (39.9) 116 (60.1) 0.28
(0.20–
0.40)
0.23 (0.14–0.38) 6.20
(3.04)
2.39 (2.77
to 2.00)
2.14 (2.53
to 1.75)
Perception of side-effects No – – – – 9.17
(1.13)
Reference Reference
Yes 8.62
(1.61)
0.54 (0.78
to 0.31)
0.53 (0.79
to 0.26)
Severity of side-effects Very mild – – – – 9.29
(1.60)
Reference Reference
Mild 8.68
(1.28)
0.61 (1.11
to 0.11)
0.63 (1.18
to 0.08)
Moderate 7.82
(1.98)
1.47 (2.11
to 0.83)
1.59 (2.27
to 0.91)
Severe 7.20
(1.92)
2.09 (3.49
to 0.69)
2.02 (3.46
(0.58)
Worry about side-effects Not at all
worried
– – – – 9.13
(1.54)
Reference Reference
Not very
worried
8.53
(1.56)
0.60 (1.18
to 0.02)
0.44 (1.07
to 0.19)
Fairly
worried
8.49
(1.25)
0.65 (1.25
to 0.04)
0.53 (1.19
to 0.13)
Very
worried
8.25
(2.63)
0.88 (1.72
to 0.04)
0.72 (1.60
to 0.16)
Results highlighted in bold are significant.
a Adjusting for all personal characteristics (both parent and child).
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influenza, cited by 61.2% of participants, whereas the most com-
monly reported reason for not vaccinating was because partici-
pants thought that the child was generally healthy and they
were not overly worried about catching influenza (43.2%), followed
by the perception that the vaccine causes side-effects (21.7%).
Associations between personal characteristics, perceptions
about influenza and the vaccine and vaccination uptake in the
2015–2016 season are reported in Tables 1 and 2. When control-
ling for all other personal characteristics, participants whose child
had a previous influenza vaccination; who believed the influenza
vaccine to be effective; perceived the child to be susceptible to
flu; had a health professional recommend that the child should
be vaccinated; and those who perceived influenza to be a serious
illness for the child had increased the odds of vaccine uptake. Fac-
tors associated with lower likelihood of uptake included: feeling
that they do not know enough about the vaccine; perceiving the
vaccine to be unsafe; believing the vaccination campaign to be only
about making money for the manufacturers; believing that the
vaccine causes short-term side-effects and long-term health prob-
lems; believing that yearly vaccination would overload the child’s
immune system; not liking vaccines in general; and believing
yearly influenza vaccinations to be too much of an ongoing time
commitment.
3.3. Side-effect perception
Of participants who reported that their child had been vacci-
nated, 215 (41.0%) indicated that their child had experienced at
least one side-effect. The most common side-effect reported was
runny or stuffy nose (n = 84, 16.0%). ‘‘Flu” was reported as a side-
effect by 33 participants (6.3%; see supplementary materials for
full results).
Side-effects were described as ‘‘very mild” by 52 participants
(24.3%), ‘‘mild” by 118 (55.1%), ‘‘moderate” by 39 (18.2%) and ‘‘sev-
ere” by 5 (2.3%). No-one reported ‘‘very severe” side-effects. 47
(21.8%) participants indicated that they were ‘‘not at all worried”
about their child’s side-effects, 80 (37.0%) stated that they were
‘‘not very worried,” 68 (31.5%) were ‘‘fairly worried” and 21
(9.7%) were ‘‘very worried.”
Associations between personal characteristics, perceptions
about influenza and the vaccine, and perception of side-effects
are reported in Tables 3 and 4. When controlling for all other per-
sonal characteristics, participants were more likely to report side-
effects if the child had a chronic illness or was first-born. Partici-
pants had increased odds of perceiving side-effects if they: knew
another child who had experienced side-effects from the influenza
vaccine; thought that the influenza vaccine would interact with
other medications that the child was taking; believed that yearly
influenza vaccination was too much of an ongoing time commit-
ment; believed that yearly vaccination will overload the immune
system; believed the influenza vaccine can cause short-term
side-effects or long-term health problems; believed the vaccine
goes against one’s religious or cultural beliefs; believed that the
vaccination campaign is just about making money for the manu-
facturers; had a health professional, friend or relative recommend
that the child should not be vaccinated; believed the vaccine to be
unsafe; did not like vaccines for the child in general; believed influ-
enza to be a serious illness for the child, oneself or someone in the
child’s household; or felt they did not know enough about the vac-
cine. Female participants and older participants were less likely to
report side-effects.
3.4. Intended vaccine uptake
668 (70.3%) participants had a high intention to vaccinate their
child in the 2016–2017 influenza season. Associations between
personal characteristics, perceptions about influenza and the vac-
cine, and intention to vaccinate in the 2016–2017 season are
reported in Tables 1 and 2. The pattern of results for intention to
vaccinate was broadly similar to that for reported uptake. Partici-
pants who perceived side-effects following vaccination in the
2015–2016 influenza season were less likely to intend to vaccinate
their child the following year, as were those who knew another
child who had experienced side-effects from the vaccine. In those
participants who stated that their child had experienced a side-
effect as a result of the influenza vaccine, perceived severity of
the side-effect was associated with decreased intention to vacci-
nate one’s child.
3.5. Terminology used in vaccine communications
The correct interpretation of ‘‘50% vaccine effectiveness” was
selected by 195 participants (19.5%; see supplementary materials).
The most commonly endorsed option was that ‘‘50% of children
who have the vaccine will be immune to flu” (28.8%, n = 288).
Estimates of the incidence of acute side-effects with different
verbal descriptors of risk are reported in the supplementary mate-
rials. The median estimate for a ‘‘very common” side-effect was
5000 in every 10,000 children (1 in 2), 2000 for ‘‘common side-
effects” (1 in 5), 199 for ‘‘uncommon side-effects (1 in 50) and 50
for ‘‘very rare” side-effects (1 in 200). Interquartile ranges for these
estimates overlapped greatly.
4. Discussion
We observed similar child influenza vaccine uptake rates
(52.8%) as national estimates [4]. However, over 70% of partici-
pants reported intending to vaccinate their child in the 2016–
2017 influenza season. Rather than reflecting a sudden increase
in uptake between the two influenza seasons, this difference prob-
ably reflects the gap between intentions and behaviours that is
commonly observed across many health behaviours [23].
The largest effect exerted by any factor on uptake was that of
having previously vaccinated the child against influenza, a com-
mon finding in the literature [9,20,24]. Parental perceptions and
attitudes were also strongly associated with uptake and intended
uptake. In line with theories regarding factors that predict uptake
of health protective behaviours [25] and other findings in the
wider literature [9,10], perceptions about the risk associated with
influenza (severity of the illness and child vulnerability) and
believing the vaccine to be an effective way of reducing this risk
were associated with uptake. Factors relating to possible future
adverse events caused by the vaccine, such as it causing short-
term side-effects, long-term health problems and overloading the
child’s immune system, were associated with a decrease in the
odds of vaccination, as was perceiving the vaccine to be unsafe.
These factors were also strongly associated with intention to vac-
cinate the child in the 2016–2017 season.
Observing side-effects following vaccination was associated
with reduced intention to vaccinate the child again next year, a
result also seen in other studies [11]. Of those who vaccinated their
child, 41% perceived acute side-effects, in line with clinical trial
data [26]. Beliefs and perceptions relating to possible adverse
effects from the vaccine greatly increased the odds of perceiving
side-effects. Social influences, including knowing another child
who had experienced side-effects from the influenza vaccine and
having friends, relatives or a health professional recommend
against vaccination, were also found to predict perception of
side-effects. These factors may contribute to parents’ expectations
that their child will experience side-effects following vaccination,
with this expectation becoming self-fulfilling [12,13]. Personal
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characteristics that may link to perceptions of a child’s general vul-
nerability, including whether the child had a chronic illness or was
first-born also predicted parental perception of side-effects.
Our identification of strong predictors of vaccine uptake, per-
ception of side-effects and intended uptake has important implica-
tions for future communications about the child influenza vaccine.
To improve uptake, messages to parents should be targeted at per-
ceptions that are both amenable to change and strongly associated
with lack of uptake or side-effect reporting, in particular those sur-
rounding possible future adverse events that may occur as a result
of the vaccine. Communications should also emphasise that the
vaccine is safe and effective while highlighting that children are
susceptible to and are at risk of developing complications from
influenza. In addition, all healthcare providers should be encour-
aged to provide strong vaccine recommendations; data indicate
that almost half of participants disagreed that a health professional
had recommended vaccination. In order to assess the impact of
specific attitudes and perceptions, we treated answers of ‘‘don’t
know” and ‘‘neither agree nor disagree” as missing data. In prac-
tice, approximately 5% and 15–25% of participants provided such
responses for each item respectively. This suggests that a substan-
tial proportion of the public are willing to admit their lack of
knowledge about these issues and may be open to new
information.
Implementing an effective communication strategy targeting
these variables presents a number of challenges. Terminology used
in past communications about the influenza vaccine discusses the
‘‘effectiveness” of vaccines [27,28], however, this terminology was
found to be incompletely understood by participants. Given the
association between perceived efficacy and uptake, research on
how best to communicate about efficacy should now be a priority.
Terminology surrounding the incidence of side-effects following
Table 3
Participants’ personal characteristics and associations with perception of side-effects.
Parent characteristics Level Perception of side-effectsc
Perceived side-
effects n = 216
No perceived side-
effects n = 310
Odds ratio
(95% CI)
Adjusted odds ratio
(95% CI)b
Parent gender Male 97 (46.0) 114 (54.0) Reference Reference
Female 118 (37.6) 196 (62.4) 0.71 (0.50–
1.01)
0.65 (0.42–0.99)
Parent age 18–34 117 (47.6) 129 (52.4) Reference Reference
35–44 84 (35.6) 152 (64.4) 0.57 (0.29–
0.82)
0.58 (0.38–0.88)
45+ 14 (26.9) 38 (73.1) 0.38 (0.20–
0.73)
0.45 (0.21–0.96)
Employment Not working 44 (35.2) 81 (64.8) Reference Reference
Working 171 (42.8) 229 (57.3) 1.38 (0.91–
2.09)
0.96 (0.57–1.60)
Total household income before tax and
other deductions
Under <£30,000 75 (39.5) 115 (60.5) Reference Reference
£30,000 132 (42.9) 176 (57.1) 1.15 (0.80–
1.66)
0.93 (0.60–1.45)
Parent highest educational or
professional qualification
GCSE/vocational/A-level/No
formal qualifications
75 (32.9) 153 (67.1) Reference Reference
Degree or higher (Bachelors,
Masters, PhD)
137 (47.7) 150 (52.3) 1.86 (1.30–
2.67)
1.51 (0.97–2.36)
Ethnicity White 178 (39.2) 276 (60.8) Reference Reference
Black and Minority 35 (54.7) 29 (45.3) 1.87 (1.11–
3.17)
1.55 (0.85–2.80)
Parent chronic illness None 139 (40.6) 203 (59.4) Reference Reference
Present 75 (41.7) 105 (58.3) 1.04 (0.72–
1.51)
1.05 (0.68–1.63)
Child gender Male 118 (45.7) 140 (54.3) Reference Reference
Female 97 (36.3) 170 (63.7) 0.68 (0.48–
0.96)
0.74 (0.50–1.09)
First-born child No 64 (30.9) 143 (69.1) Reference Reference
Yes 151 (47.5) 167 (52.5) 2.02 (1.40–
2.92)
1.61 (1.06–2.43)
Child agea 4.52 (1.68) 0.95 (0.86–
1.05)
0.95 (0.84–1.06)
Child chronic illness None 159 (38.1) 258 (61.9) Reference Reference
Present 54 (52.4) 49 (47.6) 1.79 (1.16–
2.76)
1.67 (1.01–2.78)
Child previous flu vaccine No 25 (32.1) 53 (67.9) Reference Reference
Yes 189 (43.8) 243 (56.3) 1.65 (0.99–
2.75)
1.43 (0.80–2.53)
Results highlighted in bold are significant.
a Continuous variable. Presented as mean (sd).
b Adjusting for all personal characteristics (both parent and child).
c When asked why they had not vaccinated their child, three people indicated that they had answered the vaccination question incorrectly and that they had indeed
vaccinated their child; these participants’ results were recoded, but because of the scripting of the questionnaire, they were not asked side-effect perception questions. One
participant who stated that their child had been vaccinated could not remember whether they had experienced any side-effects, therefore side-effect perception data for this
participant were removed from the analysis As such, side-effect perception data for 525 parents is presented.
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vaccination used in past communications [21,29] also gave rise to
elevated estimates of incidence [30,31]. Verbal descriptors of risk
often result in elevated estimates of incidence [30,31], something
reflected in our findings where for three out of four verbal descrip-
tors of risk, median estimates of incidence of side-effects were
higher than those described in the patient information leaflet
Table 4
Associations between attitudes and perceptions and perception of side-effects.
Perception statement Level Perception of side-effects
Perceived side-
effects n = 216
No perceived side-
effects n = 310
Odds ratio
(95% CI)a
Adjusted odds ratio
(95% CI)
The child flu vaccine has not been tested enough for me to feel
it is safe
Disagree 103 (33.0) 209 (67.0) Reference Reference
Agree 59 (66.3) 30 (33.7) 3.99 (2.42–
6.57)
3.31 (1.87–5.88)
The child flu vaccine can cause unpleasant short-term side-
effects
Disagree 37 (24.5) 114 (75.5) Reference Reference
Agree 131 (63.9) 74 (36.1) 5.45 (3.42–
8.71)
6.11 (3.61–10.35)
The child flu vaccine can cause long-term health problems Disagree 88 (30.2) 203 (69.8) Reference Reference
Agree 63 (73.3) 23 (26.7) 6.32 (3.69–
10.83)
5.16 (2.70–9.85)
The flu vaccine would interact with other medications that
[child] is currently taking
Disagree 116 (31.7) 250 (68.3) Reference Reference
Agree 56 (78.9) 15 (21.1) 8.05 (4.37–
14.82)
7.18 (3.42–15.04)
Vaccinating [child] against flu each year will overload his/her
immune system
Disagree 99 (31.6) 214 (68.4) Reference Reference
Agree 68 (75.6) 22 (24.4) 6.68 (3.91–
11.43)
5.65 (2.96–10.80)
Another child I know had side-effects from the vaccine Disagree 79 (25.6) 230 (74.4) Reference Reference
Agree 83 (74.1) 29 (25.9) 8.33 (5.08–
13.66)
7.27 (4.11–12.83)
A health professional has recommended that [child] should be
vaccinated
Disagree 36 (32.4) 75 (67.6) Reference Reference
Agree 136 (48.4) 145 (51.6) 1.95 (1.23–
3.10)
1.66 (0.98–2.82)
A health professional has recommended that [child] shouldn’t
be vaccinated
Disagree 130 (34.4) 248 (65.6) Reference Reference
Agree 61 (73.5) 22 (26.5) 5.29 (3.11–
9.00)
4.17 (2.25–7.72)
A friend/relative has recommended that [child] shouldn’t be
vaccinated
Disagree 118 (32.9) 241 (67.1) Reference Reference
Agree 59 (65.6) 31 (34.4) 3.89 (2.39–
6.33)
3.46 (1.94–6.15)
If I don’t vaccinate [child], then [child] will get flu Disagree 27 (41.5) 38 (58.5) Reference Reference
Agree 112 (50.2) 111 (49.8) 1.42 (0.81–
2.48)
1.11 (0.57–2.18)
Flu would be a serious illness for [child] Disagree 13 (19.1) 55 (80.9) Reference Reference
Agree 164 (44.6) 204 (55.4) 3.40 (1.80–
6.44)
2.43 (1.19–4.98)
Flu would be a serious illness for me Disagree 31 (27.9) 80 (72.1) Reference Reference
Agree 139 (48.4) 148 (51.6) 2.42 (1.51–
3.90)
2.45 (1.41–4.24)
Flu would be a serious illness for someone living in [child]’s
household
Disagree 28 (28.9) 69 (71.1) Reference Reference
Agree 131 (43.8) 168 (56.2) 1.92 (1.17–
3.15)
1.84 (1.04–3.25)
Having the child flu vaccine is an effective way of preventing
[child] from catching flu
Disagree 15 (53.6) 13 (46.4) Reference Reference
Agree 169 (39.8) 256 (60.2) 0.572 (0.27–
1.23)
0.54 (0.22–1.28)
I don’t like [child] having vaccinations in general Disagree 98 (32.2) 206 (67.8) Reference Reference
Agree 65 (63.1) 38 (36.9) 3.60 (2.25–
5.74)
2.91 (1.71–4.94)
I don’t know enough about the child flu vaccine Disagree 82 (34.2) 158 (65.8) Reference Reference
Agree 64 (52.0) 59 (48.0) 2.09 (1.34–
3.26)
2.09 (1.26–3.46)
Vaccinating [child] against flu each year is too much of an
ongoing time commitment
Disagree 117 (31.0) 260 (69.0) Reference Reference
Agree 63 (76.8) 19 (23.2) 7.37 (4.22–
12.87)
6.16 (3.17–11.98)
The child flu vaccine does not suit my religious or cultural
beliefs/values
Disagree 124 (32.5) 257 (67.5) Reference Reference
Agree 56 (75.7) 18 (24.3) 6.45 (3.64–
11.43)
4.94 (2.55–9.57)
The vaccination campaign is just about making money for the
manufacturers
Disagree 105 (33.8) 206 (66.2) Reference Reference
Agree 56 (72.7) 21 (27.3) 5.23 (3.01–
9.10)
4.49 (2.33–8.66)
Results highlighted in bold are significant.
a Adjusting for all personal characteristics (both parent and child).
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[21]. Additional research on how best to communicate this infor-
mation is required.
One limitation of this study is its cross-sectional design, making
causal inferences difficult to draw for some of the associations we
observed. This is particularly problematic with respect to the asso-
ciation between perceptions and side-effect reporting. While it is
possible that negative perceptions of the vaccine lead to an
increased likelihood of side-effects being observed, it is also possi-
ble that observing side-effects leads to negative perceptions. In
order to disentangle the direction of causality, a longitudinal study
should be conducted. A second limitation relates to selection bias.
Whether members of market research panels are psychologically
representative of the general population in terms of attitudes to
vaccination is unknown [32]. While it is possible that parents
who had vaccinated their child were more likely to complete the
study, rates of reported uptake were in line with national figures
[4]. Particular strengths of the study include the timing of data col-
lection soon after the end of the influenza vaccination campaign
[33], reducing the likelihood of recall bias for our outcome
measures.
This study is the first to investigate parental perceptions sur-
rounding the newly introduced child influenza vaccine in the UK
and the first to investigate the association between attitudes and
side-effect perception following immunisation. Although a causal
link cannot definitively be established, our data are consistent with
the theory that past behaviour, attitudes and social influences
affect both uptake and side-effect perception. Terminology cur-
rently used to describe vaccine side-effects in communications
leads people to estimate a higher incidence of side-effects. Efforts
to improve uptake should now focus on tackling these perceptions.
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